NDC 17856-0353-2 - Pharbetol Regular strength
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-0353
- Requested NDC
- 17856-0353-2
- Package NDCs from labels
- 17856-0353-2, 17856-0353-1, 17856-0353-4, 17856-0353-3
- Manufacturer
- ATLANTIC BIOLOGICALS CORP.
- Effective date
- 2025-06-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| PHARBEST IBUPROFEN Drug Facts | ATLANTIC BIOLOGICALS CORP. | 2025-06-05 | HUMAN OTC DRUG LABEL |
| Pharbetol Regular strength - ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS | ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS | 2024-04-30 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 17856-0353-1 | 2024-06-26 | C162847 | 48780-1 | 1030e365-250f-111a-e063-dadaa90a10e2 | PHARBEST IBUPROFEN Drug Facts |
| 17856-0353-1 | 2024-01-30 | C162847 | 48780-1 | 1030e365-250f-111a-e063-dadaa90a10e2 | PHARBEST IBUPROFEN Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0353-1 | PharbetolRegular strength | 100 in 1 BOX, UNIT-DOSE | TABLET | 100 | 3 | |
| 17856-0353-2 | PharbetolRegular strength | 1 in 1 POUCH | TABLET | 1 | 3 | |
| 17856-0353-4 | PharbetolRegular strength | 24 in 1 BOTTLE | TABLET | 24 | 3 | |
| 17856-0353-3 | PharbetolRegular strength | 28 in 1 BOTTLE | TABLET | 28 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-0353 | PHARBETOL REGULAR STRENGTH (ACETAMINOPHEN) TABLET [ATLANTIC BIOLOGICALS CORP.] | 2 | Current NDC, Legacy NDC, 3 package rows | 20240627_05a91d24-b498-4ba2-a275-68b871cf62d2.zip |
| 17856-0353 | PHARBETOL REGULAR STRENGTH (ACETAMINOPHEN) TABLET [ATLANTIC BIOLOGICALS CORP.] | 1 | Current NDC, Legacy NDC, 1 package rows | 20240508_bd26081c-e81e-42e8-b3da-2813863a51df.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydrocodone Bitartrate and Acetaminophen | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | Bryant Ranch Prepack | 94ba2279-440e-4eaf-ad19-04d90a5c4c10 | 2025-10-21 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Hydrocodone Bitartrate and Acetaminophen | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | Bryant Ranch Prepack | 177c4cd8-80dd-4ed7-9e12-dcec70e0278e | 2025-10-21 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| iVIZIA Dry Eye | POVIDONE | Thea Pharma Inc. | 1ef73cb1-da48-a713-e063-6294a90afa9d | 2025-10-20 | Warnings | FZ989GH94E |
| Walgreens Antacid Pain Relief Extra Strength | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Walgreens | b60df498-07db-500b-e053-2a95a90aff6a | 2025-10-17 | Warnings | M013 |
| Equate Effervescent Antacid and Pain Relief | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Walmart | 6271b34b-55a0-40a8-e053-2a91aa0acb22 | 2025-10-17 | Warnings, Adverse reactions | M013 |
| Norel AD | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND PHENYLEPHRINE HCL | U.S. PHARMACEUTICAL CORPORATION | 53d9ed3c-212d-4b12-ac35-8bd49382b49d | 2025-10-17 | Warnings | 362O9ITL9D |
| Xesso Neo | BENZOCAINE | PREMIUM NATURAL COSMETICS INC | 163f32cd-4e51-950a-e063-6394a90a4816 | 2025-10-17 | Warnings | M013 |
| Menstrual Complete Maximum Strength | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | CHAIN DRUG MARKETING ASSOCIATION INC | 913d8bdb-7644-464c-b9a6-55387ff12059 | 2025-10-17 | Warnings | M013 362O9ITL9D |
| Alka-Seltzer Hangover Relief | ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE | Bayer HealthCare LLC. | dc235b06-999e-221d-e053-2a95a90a0ce1 | 2025-10-16 | Warnings | M013 |
| Butalbital And Acetaminophen | BUTALBITAL AND ACETAMINOPHEN | Larken Laboratories, Inc. | 326c83fc-afed-45ad-9c87-f47968fa1d2a | 2025-10-15 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Aspirin 81mg | ASPIRIN ENTERIC COATED TABLETS 81MG | VITANE PHARMACEUTICALS, INC | 41386de5-5857-efab-e063-6294a90afd9c | 2025-10-15 | Warnings | M013 |
| Aspirin 81mg | ASPIRIN ENTERIC COATED TABLETS 81MG | VITANE PHARMACEUTICALS, INC | 4138d4c0-baa5-1f20-e063-6394a90a788f | 2025-10-15 | Warnings | M013 |
| TEXACLEAR PAIN RELIEVER | CAFFEINE, CHOLINE SALICYLATE | GM Pharmaceuticals, INC | 065bd10c-3bcf-486f-a49c-40544127007f | 2025-10-15 | Warnings | M013 |
| Daytime Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL | Care One (Retail Business Services, LLC.) | 6ca7372b-50c4-4b15-b133-fefa35525ade | 2025-10-15 | Warnings | 362O9ITL9D |
| ACETAMINOPHEN 500 MG | ACETAMINOPHEN | ASCLEMED USA INC. | db8e6702-88ac-4db2-9dd8-7d0ed997c2b5 | 2025-10-14 | Warnings | M013 362O9ITL9D |
| Pain Reliever Extra Strength | ACETAMINOPHEN | Walgreen Company | fa33f6ef-522b-4630-9716-92371d9cd24a | 2025-10-14 | Warnings | M013 362O9ITL9D |
| Nitetime Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL | Meijer Distribution Inc | 47f03174-6e91-4529-bbfa-ce58aa7b7d79 | 2025-10-13 | Warnings | 362O9ITL9D |
| acetaminophen | ACETAMINOPHEN | Rite Aid Corporation | a8bb4f45-7a1a-4bf7-92ca-3afd508032f3 | 2025-10-09 | Warnings | M013 362O9ITL9D |
| Pain Reliever | ACETAMINOPHEN | Health Pharma USA LLC | b15a7dcb-f143-4aea-8850-d0aacbf709b6 | 2025-10-09 | Warnings | M013 362O9ITL9D |
| Giltuss MultiSymptom Cold and Flu | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE | Giltuss Pharmaceutical Corp | 8518fd91-981e-de78-e053-2a91aa0afcb2 | 2025-10-09 | Warnings | 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.